SIX1 and hepatocellular carcinoma: In summary, the results of our study identified a new mechanism in which miR‐204‐5p suppressed HCC proliferation by directly regulating SIX1 and its downstream factors both in vitro and in vivo, suggesting that these molecules may be potential targets for HCC treatment.